Sinclair Michael 13D and 13G filings for Opiant Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-17 4:52 pm Sale | 2021-08-23 | 13D | Opiant Pharmaceuticals, Inc. OPNT | Sinclair Michael | 515,170 9.300% | -230,000 (-30.87%) | Filing |